Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4438733 | 0.82 | CYP3A4 (0.39) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| SCHEMBL8086732 | 0.77 | CYP3A4 (0.37) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| SCHEMBL2807841 | 0.77 | CYP3A4 (0.37) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| SCHEMBL3787796 | 0.73 | TDP1 (0.33) | CYP3A4TDP1ALDH1A1TP53HSD17B10 | |
| SCHEMBL298214 | 0.73 | KIF11 (0.37) | CYP3A4TDP1ALDH1A1TP53 | |
| SCHEMBL8089981 | 0.73 | ALDH1A1 (0.33) | CYP3A4TDP1ALDH1A1TP53 | |
| SCHEMBL5080738 | 0.70 | ALDH1A1 (0.36) | CYP3A4TDP1ALDH1A1TP53HSD17B10 | |
| SCHEMBL844893 | 0.65 | CYP3A4 (0.37) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| Hydrochloric Acid SCHEMBL7556367 | 0.64 | CYP3A4 (0.36) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| Hydrochloric Acid SCHEMBL18986246 | 0.63 | CYP3A4 (0.34) | CYP3A4TDP1ALDH1A1TP53TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0043675-B1 | MODIFIED HEMOGLOBINS SUITABLE FOR USE AS OXYGEN CARRIERS FOR BLOOD SUBSTITUTES | AJINOMOTO CO., INC. (JP) | 1984-10-03 | — | — | EP | claimed |
| US-4377512-A | ESTERIFICATION INULIN AND REACTING WITH HEMOGLOBIN | AJINOMOTO CO., INC. (JP) | 1983-03-22 | — | — | US | claimed |
| EP-0043675-A1 | Modified hemoglobins suitable for use as oxygen carriers for blood substitutes | AJINOMOTO CO., INC. (JP) | 1982-01-13 | — | — | EP | claimed |
| US-20260131280-A1 | GAS SEPARATION MEMBRANE UNIT, GAS SEPARATION SYSTEM, AND METHOD FOR PRODUCING ENRICHED GAS | UBE CORP (JP) | 2026-05-14 | — | — | US | disclosed |
| CN-103796674-A | Composition with means for targeting at least one antigen to dendritic cells | INST CURIE | 2014-05-14 | — | — | CN | disclosed |
| US-5691443-A | AROMATIC POLYAMIDES FOR ROPES AND COMPOSITES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-11-25 | — | — | US | disclosed |
| US-5459231-A | Comonomers of 2,2*-disubstituted-4,4*-diaminobiphenyls, terephthalic acid, and p-phenylenediamine; composites, ropes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-10-17 | — | — | US | disclosed |
| US-4530993-A | Poly 2,2'-dichloro-4,4'-biphenylene pyromellitimide film | DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) | 1985-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260131280-A1 | GAS SEPARATION MEMBRANE UNIT, GAS SEPARATION SYSTEM, AND METHOD FOR PRODUCING ENRICHED GAS | SCO2, SLC2A4, STOML2 | CYP3A4 1207/4885TDP1 4647/4885ALDH1A1 4807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.